When asked whether the cap on the number of paid MURs should be amended, 61% – 68 of the 112 respondents to a poll, which ran on the C+D website from May 1-10 – said the service “should be stopped entirely”.
A further 19% said the MUR cap should be removed, while 9% of respondents said the current cap of 400 a year should be raised.
Just 6% of pharmacists and staff responding to C+D’s snapshot poll were in favour of keeping the current cap, while 5% voted to lower it.
The Pharmaceutical Services Negotiating Committee has said discussions around the future of the MUR service will form part of negotiations for the 2019-20 pharmacy contract, which officially began last month.
Result
Should the cap of the number of paid medicines use reviews be amended?
Yes, it should be removed
19%
Yes, it should be raised
9%
Yes, it should be lowered
5%
No, it should remain at 400 a year
6%
The service should be stopped entirely
61%
Total votes: 112
What’s next for MURs? Read C+D’s analysis on the future of the pharmacy service and pharmacists' thoughts on whether it should be redesigned, refined or scrapped.